Reporting system of suspected adverse effects from electronic cigarettes and refill liquids in Europe.

adverse effects electronic cigarettes reporting system

Journal

Tobacco prevention & cessation
ISSN: 2459-3087
Titre abrégé: Tob Prev Cessat
Pays: Greece
ID NLM: 101693412

Informations de publication

Date de publication:
2021
Historique:
received: 04 10 2021
accepted: 05 11 2021
entrez: 30 12 2021
pubmed: 31 12 2021
medline: 31 12 2021
Statut: epublish

Résumé

In line with Article 20 (9) of the Tobacco Products Directive (TPD) 2014/40/EU, a guidance document outlining a reporting system of suspected adverse effects from electronic cigarettes and their refill liquids was produced by Work Package 4 entitled 'Integration into national policies and sustainability' of the Joint Action on Tobacco Control (JATC). The JATC was a European project that lasted three years (2017-2020), with the general objective of providing support for the implementation of the TPD throughout the 27 European Union Member States (EU MS). The reporting system described in the guidance document includes a short reporting template for the reporting of adverse effects on human health from electronic cigarettes and refill liquids, both by Economic Operators (EO) and by National Competent Authorities (NCA). The present guidance document aims at providing the necessary steps and modalities that each MS should follow if involved in the development of a system for the reporting of suspected adverse effects on human health from electronic cigarettes and refill liquids.

Identifiants

pubmed: 34966878
doi: 10.18332/tpc/143331
pii: 71
pmc: PMC8662365
doi:

Types de publication

Journal Article

Langues

eng

Pagination

71

Informations de copyright

© 2021 Solimini R. et al.

Déclaration de conflit d'intérêts

The authors have each completed and submitted an ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.

Références

Hum Exp Toxicol. 2021 Jun;40(6):1045-1050
pubmed: 33272061
Tob Induc Dis. 2020 Nov 10;18:93
pubmed: 33209101
Int J Environ Res Public Health. 2020 Mar 27;17(7):
pubmed: 32230711
Tob Induc Dis. 2018 Aug 05;16:A1
pubmed: 31516457
Tob Induc Dis. 2020 Sep 14;18:77
pubmed: 33013273
Tob Induc Dis. 2019 Dec 11;17:91
pubmed: 31892921
Medicine (Baltimore). 2018 May;97(19):e0324
pubmed: 29742683

Auteurs

Renata Solimini (R)

National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy.

Caitriona Stack (C)

National Tobacco Control Office, Oak House, Millennium Park, Naas, Ireland.

Kathleen Clifford (K)

National Tobacco Control Office, Oak House, Millennium Park, Naas, Ireland.

Laszlo Bencze (L)

Health Services Management Training Centre, Semmelweis University, Budapest, Hungary.

Francisco M Ruiz Dominguez (FM)

Consejería de Salud de la Junta de Andalucía, Andalusian Regional Ministry of Health and Families, General Directorate of Public Health, Service of Health Promotion and Local Action in Health, Sevilla, Spain.

Constantine Ι Vardavas (CΙ)

George D. Behrakis Research Lab, Hellenic Cancer Society, Athens, Greece.

Panagiotis Behrakis (P)

George D. Behrakis Research Lab, Hellenic Cancer Society, Athens, Greece.
Institute of Public Health, The American College of Greece, Athens, Greece.
Athens Medical Center, Athens, Greece.

Classifications MeSH